GCP
HGEN

GSA Capital Partners’s HUMANIGEN, INC. HGEN Stock Holding History

GSA Capital Partners’s Portfolio HGEN Stock Details HGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,026,643
Closed -$185K – 2018
2022
Q3 		$185K Buy
1,026,643
+793,218
+340% +$427K 0.02% 1248
2022
Q2 		$413K Buy
233,425
+105,438
+82% +$237K 0.06% 617
2022
Q1 		$385K Buy
127,987
+2,807
+2% +$7.51K 0.05% 721
2021
Q4 		$466K Buy
+125,180
New +$732K 0.06% 646

Other funds holding HGEN

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GSA Capital Partners's HGEN Position: Q4 2022 in Review

GSA Capital Partners sold out of HUMANIGEN, INC. (HGEN) in Q4 2022, closing a stake of 1,026,643 shares — an estimated $185K sold.

GSA Capital Partners first reported a position in HGEN in Q4 2021 and held it in 4 quarters. The position peaked at $466K in Q4 2021. 48 funds tracked by Wall St. Rank hold HGEN as of Q4 2022.

  • GSA Capital Partners reported no remaining HUMANIGEN, INC. position as of Q4 2022 after selling out during the quarter.
  • GSA Capital Partners sold 1,026,643 HUMANIGEN, INC. shares in Q4 2022, an estimated $185K.
  • GSA Capital Partners first reported a position in HUMANIGEN, INC. in Q4 2021 and held it in 4 quarters.
  • GSA Capital Partners's HUMANIGEN, INC. position peaked at $466K in Q4 2021.
  • 48 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q4 2022.

Based on GSA Capital Partners's 13F filing for Q4 2022, filed 13 Feb 2023.